Glycogen Synthase Kinase (GSK)-3 Promotes P70 Ribosomal Protein S6 Kinase (p70S6K) Activity and Cell Proliferation

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2011 Nov 9

PMID 22065737

Citations 89

Authors

Sejeong Shin

Laura Wolgamott

Yonghao Yu

John Blenis

Sang-Oh Yoon

Affiliations

Soon will be listed here.

Abstract

The p70 ribosomal protein S6 kinase 1 (S6K1) plays a key role in cell growth and proliferation by regulating insulin sensitivity, metabolism, protein synthesis, and cell cycle. Thus, deregulation of S6K contributes to the progression of type 2 diabetes, obesity, aging, and cancer. Considering the biological and clinical importance of S6K1, a complete understanding of its regulation is critical. One of the key motifs in the activation of S6K1 is a turn motif, but its regulation is not well understood. Here we provide evidence for two mechanisms of modulating turn motif phosphorylation and S6K1 activity. First, mammalian target of rapamycin regulates turn motif phosphorylation by inhibiting its dephosphorylation. Second, we unexpectedly found that glycogen synthase kinase (GSK)-3 promotes turn motif phosphorylation. Our studies show that mammalian target of rapamycin and GSK-3 cooperate to control the activity of S6K1, an important regulator of cell proliferation and growth. Our unexpected results provide a clear rationale for the development and use of drugs targeting GSK-3 to treat diseases such as diabetes, cancer, and age-related diseases that are linked to improper regulation of S6K1.

Citing Articles

Antisense oligonucleotide-mediated TRA2β poison exon inclusion induces the expression of a lncRNA with anti-tumor effects.

Leclair N, Brugiolo M, Park S, Devoucoux M, Urbanski L, Angarola B Nat Commun. 2025; 16(1):1670.

PMID: 39955311 PMC: 11829967. DOI: 10.1038/s41467-025-56913-8.

Inhibition of GSK3β is synthetic lethal with FHIT loss in lung cancer by blocking homologous recombination repair.

Tao S, Pu Y, Yang E, Ren G, Shi C, Chen L Exp Mol Med. 2025; 57(1):167-183.

PMID: 39762409 PMC: 11799392. DOI: 10.1038/s12276-024-01374-0.

The Protective Role of Transcript-Induced in Spermiogenesis 40 in Cerebral Ischemia-Reperfusion Injury.

Xie J, Wang L, Tian S, Li R, Zhang L, Shi H Neurochem Res. 2024; 49(9):2519-2534.

PMID: 38884889 DOI: 10.1007/s11064-024-04170-4.

Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy.

Dheeraj A, Marques F, Tailor D, Bermudez A, Resendez A, Pandrala M Cell Rep Med. 2024; 5(5):101552.

PMID: 38729158 PMC: 11148772. DOI: 10.1016/j.xcrm.2024.101552.

An evolutionarily conserved phosphoserine-arginine salt bridge in the interface between ribosomal proteins uS4 and uS5 regulates translational accuracy in Saccharomyces cerevisiae.

Joshi K, Luisi B, Wunderlin G, Saleh S, Lilly A, Okusolubo T Nucleic Acids Res. 2024; 52(7):3989-4001.

PMID: 38340338 PMC: 11040005. DOI: 10.1093/nar/gkae053.

References

Fingar D, Blenis J . Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene. 2004; 23(18):3151-71. DOI: 10.1038/sj.onc.1207542. View

Gao D, Wan L, Inuzuka H, Berg A, Tseng A, Zhai B . Rictor forms a complex with Cullin-1 to promote SGK1 ubiquitination and destruction. Mol Cell. 2010; 39(5):797-808. PMC: 2939073. DOI: 10.1016/j.molcel.2010.08.016. View

Fiol C, Wang A, Roeske R, Roach P . Ordered multisite protein phosphorylation. Analysis of glycogen synthase kinase 3 action using model peptide substrates. J Biol Chem. 1990; 265(11):6061-5. View

Lee J, Kim M . The role of GSK3 in glucose homeostasis and the development of insulin resistance. Diabetes Res Clin Pract. 2007; 77 Suppl 1:S49-57. DOI: 10.1016/j.diabres.2007.01.033. View

Facchinetti V, Ouyang W, Wei H, Soto N, Lazorchak A, Gould C . The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J. 2008; 27(14):1932-43. PMC: 2486276. DOI: 10.1038/emboj.2008.120. View

Barlund M, Forozan F, Kononen J, Bubendorf L, Chen Y, Bittner M . Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst. 2000; 92(15):1252-9. DOI: 10.1093/jnci/92.15.1252. View

Eldar-Finkelman H . Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med. 2002; 8(3):126-32. DOI: 10.1016/s1471-4914(01)02266-3. View

Duvel K, Yecies J, Menon S, Raman P, Lipovsky A, Souza A . Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell. 2010; 39(2):171-83. PMC: 2946786. DOI: 10.1016/j.molcel.2010.06.022. View

Saitoh M, Pullen N, Brennan P, Cantrell D, Dennis P, Thomas G . Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site. J Biol Chem. 2002; 277(22):20104-12. DOI: 10.1074/jbc.M201745200. View

10.

Barone B, Yeh H, Snyder C, Peairs K, Stein K, Derr R . Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008; 300(23):2754-64. PMC: 3093051. DOI: 10.1001/jama.2008.824. View

11.

Manoukian A, Woodgett J . Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways. Adv Cancer Res. 2002; 84:203-29. DOI: 10.1016/s0065-230x(02)84007-6. View

12.

Selman C, Tullet J, Wieser D, Irvine E, Lingard S, Choudhury A . Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science. 2009; 326(5949):140-4. PMC: 4954603. DOI: 10.1126/science.1177221. View

13.

Oh W, Wu C, Kim S, Facchinetti V, Julien L, Finlan M . mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide. EMBO J. 2010; 29(23):3939-51. PMC: 3020639. DOI: 10.1038/emboj.2010.271. View

14.

Hoeflich K, Luo J, Rubie E, Tsao M, Jin O, Woodgett J . Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature. 2000; 406(6791):86-90. DOI: 10.1038/35017574. View

15.

Schalm S, Tee A, Blenis J . Characterization of a conserved C-terminal motif (RSPRR) in ribosomal protein S6 kinase 1 required for its mammalian target of rapamycin-dependent regulation. J Biol Chem. 2005; 280(12):11101-6. DOI: 10.1074/jbc.M413995200. View

16.

Akar U, Ozpolat B, Mehta K, Lopez-Berestein G, Zhang D, Ueno N . Targeting p70S6K prevented lung metastasis in a breast cancer xenograft model. Mol Cancer Ther. 2010; 9(5):1180-7. DOI: 10.1158/1535-7163.MCT-09-1025. View

17.

Jastrzebski K, Hannan K, Tchoubrieva E, Hannan R, Pearson R . Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function. Growth Factors. 2007; 25(4):209-26. DOI: 10.1080/08977190701779101. View

18.

Doble B, Woodgett J . GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci. 2003; 116(Pt 7):1175-86. PMC: 3006448. DOI: 10.1242/jcs.00384. View

19.

Ougolkov A, Fernandez-Zapico M, Savoy D, Urrutia R, Billadeau D . Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res. 2005; 65(6):2076-81. DOI: 10.1158/0008-5472.CAN-04-3642. View

20.

Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X . TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell. 2006; 126(5):955-68. DOI: 10.1016/j.cell.2006.06.055. View